PLEASANTON, Calif. and PARIS, Nov. 6, 2023 /PRNewswire/ -- OWKIN and 10x Genomics, Inc. (TXG), announce they have entered into an agreement to add 10x Genomics spatial omics and single-cell ...

PLEASANTON, Calif., Feb. 23, 2025 /PRNewswire/ -- At the Advances in Genome Biology and Technology (AGBT) General Meeting, 10x Genomics, Inc., a leader in single cell and spatial biology, announced a ...

PALO ALTO, Calif.--(BUSINESS WIRE)--Curio Bioscience today announced it has commenced commercial operations with the launch of Curio Seeker, the world’s first high-resolution, whole-transcriptome ...

Spatial ribonucleic acid (RNA) transcriptomics measures gene expression while preserving each molecule’s coordinates in intact tissue, tying transcripts to histology and local microenvironments.

The "Spatial Genomics and Transcriptomics Market Analysis and Forecast, 2024-2034" report has been added to ResearchAndMarkets.com's offering.

10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, ...

Spatial transcriptomics is a technique that provides information about gene expression patterns within intact tissues. This technology employs various methodologies, including in situ sequencing (ISS) ...

Analyst Daniel Brennan of TD Cowen maintained a Hold rating on 10x Genomics (TXG – Research Report), retaining the price target of $18.00. Daniel Brennan has given his Hold rating due to a combination ...

In a report released yesterday, Patrick B Donnelly from Citi maintained a Buy rating on 10x Genomics (TXG – Research Report), with a price target of $23.00. Patrick B Donnelly has given his Buy rating ...